CV Sciences, Inc.
CVSI
$0.03
$0.00196.76%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.87% | -2.80% | 0.71% | -0.30% | -1.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.87% | -2.80% | 0.71% | -0.30% | -1.24% |
| Cost of Revenue | -4.28% | -8.49% | -6.17% | -10.57% | -16.29% |
| Gross Profit | 1.17% | 4.75% | 10.18% | 15.87% | 27.66% |
| SG&A Expenses | -8.45% | -6.10% | -10.32% | -13.75% | -31.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 100.00% | 100.00% | 100.00% | -- |
| Total Operating Expenses | 41.17% | 38.75% | 35.01% | 24.14% | -50.30% |
| Operating Income | -134.95% | -143.79% | -166.34% | -316.56% | 148.11% |
| Income Before Tax | -177.58% | -467.05% | -2,443.52% | -156.92% | 133.72% |
| Income Tax Expenses | -33.33% | 93.48% | 93.48% | 100.00% | 87.23% |
| Earnings from Continuing Operations | -177.18% | -443.77% | -1,741.56% | -166.89% | 133.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -177.18% | -443.77% | -1,741.56% | -166.89% | 133.96% |
| EBIT | -134.95% | -143.79% | -166.34% | -316.56% | 148.11% |
| EBITDA | -124.92% | -133.90% | -151.95% | -233.25% | 158.09% |
| EPS Basic | -166.50% | -420.83% | -2,357.14% | -20.23% | 127.91% |
| Normalized Basic EPS | -137.75% | -150.39% | -193.33% | -1,428.57% | 132.40% |
| EPS Diluted | -166.83% | -422.92% | -2,371.43% | 0.00% | 126.15% |
| Normalized Diluted EPS | -137.75% | -150.39% | -193.33% | -1,428.57% | 132.40% |
| Average Basic Shares Outstanding | 14.01% | 10.44% | 7.33% | 7.10% | 11.97% |
| Average Diluted Shares Outstanding | 14.01% | 10.44% | 7.33% | 7.10% | 11.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |